CEO Doug Biehn sits down with Nasdaq’s Leigh Hixon to share Octave’s vision of transforming neurodegenerative disease care through precision medicine. Watch Now

Get in Touch

Improving Patient Outcomes Through a Comprehensive Care Platform in MOVING-MS – A Case Study

March 4, 2024inByCommentNo Comments
Click here

© 2024 Octave Bioscience, Inc | 1440 O’Brien Drive, Suite B, Menlo Park, CA 94025 

Connect with us